Your browser doesn't support javascript.
loading
SDHC Promoter Methylation, a Novel Pathogenic Mechanism in Parasympathetic Paragangliomas.
Bernardo-Castiñeira, Cristóbal; Valdés, Nuria; Sierra, Marta I; Sáenz-de-Santa-María, Inés; Bayón, Gustavo F; Perez, Raúl F; Fernández, Agustín F; Fraga, Mario F; Astudillo, Aurora; Menéndez, Rafael; Fernández, Belén; Del Olmo, Maribel; Suarez, Carlos; Chiara, María-Dolores.
Afiliação
  • Bernardo-Castiñeira C; Head and Neck Oncology Laboratory, Institute of Sanitary Research of Asturias (ISPA), Hospital Universitario Central de Asturias, Institute of Oncology of Asturias (IUOPA), CIBERONC, Oviedo, Spain.
  • Valdés N; Service of Endocrinology and Nutrition, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Sierra MI; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), Institute of Sanitary Research of Asturias (ISPA), Hospital Universitario Central de Asturias, Universidad de Oviedo, Oviedo, Spain.
  • Sáenz-de-Santa-María I; Head and Neck Oncology Laboratory, Institute of Sanitary Research of Asturias (ISPA), Hospital Universitario Central de Asturias, Institute of Oncology of Asturias (IUOPA), CIBERONC, Oviedo, Spain.
  • Bayón GF; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), Institute of Sanitary Research of Asturias (ISPA), Hospital Universitario Central de Asturias, Universidad de Oviedo, Oviedo, Spain.
  • Perez RF; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), Institute of Sanitary Research of Asturias (ISPA), Hospital Universitario Central de Asturias, Universidad de Oviedo, Oviedo, Spain.
  • Fernández AF; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Oviedo, Spain.
  • Fraga MF; Cancer Epigenetics Laboratory, Institute of Oncology of Asturias (IUOPA), Institute of Sanitary Research of Asturias (ISPA), Hospital Universitario Central de Asturias, Universidad de Oviedo, Oviedo, Spain.
  • Astudillo A; Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Universidad de Oviedo-Principado de Asturias, Oviedo, Spain.
  • Menéndez R; Service of Pathology, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Fernández B; Service of Radiology, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Del Olmo M; Service of Nuclear Medicine, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Suarez C; Service of Endocrinology and Nutrition, Hospital Universitario la Fé, Valencia, Spain.
  • Chiara MD; Head and Neck Oncology Laboratory, Institute of Sanitary Research of Asturias (ISPA), Hospital Universitario Central de Asturias, Institute of Oncology of Asturias (IUOPA), CIBERONC, Oviedo, Spain.
J Clin Endocrinol Metab ; 103(1): 295-305, 2018 01 01.
Article em En | MEDLINE | ID: mdl-29126304
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraganglioma / Biomarcadores Tumorais / Regiões Promotoras Genéticas / Metilação de DNA / Proteínas de Membrana / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraganglioma / Biomarcadores Tumorais / Regiões Promotoras Genéticas / Metilação de DNA / Proteínas de Membrana / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha